Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06656286 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hysteroscopic Intrauterine Suturing

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Jan 1, 2026 to Jul 2, 2026 Show 5 more changesShow less
    • Completed without a posted recruiting period
    • Start date changed from estimate of Apr 25, 2025 to May 12, 2025
    • Site contact updated
    • Publications: details revised at 3 of 3 entries
    • Eligibility criteria expanded, about 2 words
  2. Start date: Feb 15, 2025 to Apr 25, 2025
    • Site contact updated
    v3
  3. Primary completion date: Jan 1, 2025 to Jan 1, 2026
    • Start date: Nov 15, 2024 to Feb 15, 2025
    • Study completion date: Jul 1, 2025 to Jul 2, 2026
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Clinical trial The aim of the study is to evaluate the safety and feasibility of intrauterine suturing with Apollos X-tack, inserted into the uterus by hysteroscope. Primary outcome: Intrauterine suture will sustain the procedure - when the uterus will be opened the suture will be observed. Secondary outcome: Procedure complications. Study Design Interventional pilot Study Study group: Women undergoing laparoscopic hysterectomy.
Trial Details
NCT Number NCT06656286
Lead Sponsor HaEmek Medical Center, Israel
Conditions
(from sponsor)		 Niche, Uterine Disease
Related terms Uterine Diseases
Enrollment 2 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov